Autoimmune Hemolytic Anemia After mRNA COVID Vaccine.

Zainab Fatima Blair R A ReeceJ Suzanne MooreRobert T Means

Published in: Journal of investigative medicine high impact case reports (2022)

Discussion of the hematologic complications of vaccination for severe acute respiratory syndrome coronavirus-2 (COVID-19) has primarily focused on the development of vaccine-associated immune thrombosis with thrombocytopenia (VITT). Other hematologic complications are uncommon. We report the case of a patient who developed immunoglobulin G (IgG)-mediated autoimmune hemolytic anemia (AIHA) after the Moderna COVID-19 messenger ribonucleic acid (mRNA) vaccine.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
multiple sclerosis
chronic kidney disease
risk factors
iron deficiency
binding protein
case report
drug induced